Besides, CRY2, PER1, and RORA exerted opposite impacts against TIMELESS on immune cell infiltration and cancer-related signaling pathways, affecting the overall survival of HCC patients. This evidence concerns the gene TIMELESS and hepatocellular carcinoma.